Osteoprotegerin/TNFRSF11B Polyklonaler Antikörper

Osteoprotegerin/TNFRSF11B Polyklonal Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 11534-1-PBS

Synonyme

Tumor necrosis factor receptor superfamily member 11B, TNFRSF11B, Osteoprotegerin, Osteoclastogenesis inhibitory factor, OPG



Geprüfte Anwendungen

Produktinformation

11534-1-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA Osteoprotegerin/TNFRSF11B und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen Osteoprotegerin/TNFRSF11B fusion protein Ag2139
Vollständiger Name tumor necrosis factor receptor superfamily, member 11b
Berechnetes Molekulargewicht 401 aa, 46 kDa
Beobachtetes Molekulargewicht56 kDa
GenBank-ZugangsnummerBC030155
Gene symbol TNFRSF11B
Gene ID (NCBI) 4982
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Osteoprotegerin (OPG), also known as tumor necrosis factor receptor superfamily member 11B (TNFRSF11B) and osteoclastogenesis inhibitory factor (OCIF), belongs to the tumor necrosis factor (TNF) receptor superfamily. By binding to RANKL, OPG inhibits osteoclastic activity and promoting bone formationis. OPG plays a key role on cell survival by inhibiting TRAIL-induced apoptosis. OPG also is involved in vascular biology, fibrosis, immunity, EMT, and the apoptosis of cancer cells (PMID: 35523775).